|Articles|April 12, 2011

Applied Clinical Trials LIVE BLOG

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots

ByAndy Studna, Senior Editor

July 8th 2026

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

ByLiz Beatty,Andy Studna, Senior Editor

July 7th 2026

Could Selective Safety Data Collection Become the Industry's New Default?

ByRob DiCicco,Andy Studna, Senior Editor

July 7th 2026

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models

ByAndy Studna, Senior Editor

July 7th 2026

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution

ByRob DiCicco,Andy Studna, Senior Editor

July 6th 2026

Applied Clinical Trials LIVE BLOG

Related Content

ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

Could Selective Safety Data Collection Become the Industry's New Default?

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution

Trending on Applied Clinical Trials Online

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models

Operational Pragmatism in ePRO-heavy trials

Could Selective Safety Data Collection Become the Industry's New Default?

Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution